Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: A collaborative meta-analysis of 11 randomized controlled trials

Europace

Volumn 17, Issue 6, 2015, Pages 855-863

  Patti, Giuseppe ^a   Bennett, Rachel ^b   Seshasai, Sreenivasa Rao Kondapally ^b   Cannon, Christopher P ^c   Cavallari, Ilaria ^a   Chello, Massimo ^a   Nusca, Annunziata ^a   Mega, Simona ^a   Caorsi, Carlos ^d   Spadaccio, Cristiano ^e,f   Keun On, Young ^g   Mannacio, Vito ^h   Berkan, Ocal ⁱ   Yilmaz, Mehmet B ⁱ   Katrancioglu, Nurkay ⁱ   Ji, Qiang ^j   Kourliouros, Antonios ^k   Baran, Çaʇdaş ^l   Pasceri, Vincenzo ^m   Akar, Ahmet Rüçhan ^l   Kaski, Juan Carlos ^b   Di Sciascio, Germano ^a   Ray, Kausik K ^b   more..

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Hospital Clinico de la Fuerza Aerea de Chile   (Chile)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f DEPARTMENT OF CARDIOLOGY   (Belgium)

^g Sungkyunkwan University School of Medicine   (South Korea)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^j TONGJI UNIVERSITY   (China)

^k KING S COLLEGE HOSPITAL   (United Kingdom)

^l ANKARA UNIVERSITY   (Turkey)

^m SAN FILIPPO NERI HOSPITAL   (Italy)

more..

Author keywords

Cardiac surgery; Meta analysis; Postoperative atrial fibrillation; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; DRUG EFFICACY; ELECTIVE SURGERY; HEART SURGERY; HUMAN; INFLAMMATION; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); ODDS RATIO; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84937821398     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv001     Document Type: Article

References (60)

1. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001;135:1061-73.
2. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery.N Engl J Med 1997;336:1429-34.
3. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al.Amulticenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-9.
4. Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA. Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005; 128:9-16.
5. Gaudino M, Andreotti F, Zamparelli R, Di Castelnuovo A, Nasso G, Burzotta F, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003;108:195-9.
6. Abdelhadi RH, Gurm HS, VanWagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004;93:1176-78.
7. Fontes ML, Mathew JP, Rinder HM, Zelterman D, Smith BR, Rinder CS. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 2005;101:17-23.
8. Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol 2005;46:1425-33.
9. McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebocontrolled trial. Lancet 2004;363:2015-21.
10. Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace 2011;13: 308-28.
11. Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. Europace 2011;13: 610-25.
12. PanW, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004;110:II45-9.
13. Marín F, Pascual DA, Roldán V, Arribas JM, Ahumada M, Tornel PL. et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 2006;97:55-60.
14. Mariscalco G, Lorusso R, Klersy C, Ferrarese S, Tozzi M, Vanoli D, et al. Observational studyon the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 2007;84:1158-64.
15. Thielmann M, Neuhäuser M, Marr A, Jaeger BR, Wendt D, Schuetze B, et al. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007;134:1143-9.
16. Powell BD, Bybee KA, Valeti U, Thomas RJ, Kopecky SL, Mullany CJ, et al. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol 2007;99:785-9.
17. Lertsburapa K, White CM, Kluger J, Faheem O, Hammond J, Coleman CI. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg 2008;135:405-11.
18. Kourliouros A, De Souza A, Roberts N, Marciniak A, Tsiouris A, Valencia O, et al. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg 2008;85:1515-20.
19. Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, et al. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J 2008;155:541-6.
20. Miceli A, Fino C, Fiorani B, Yeatman M, Narayan P, Angelini GD et al. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2009;87: 1853-8.
21. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006;114: 1455-61.
22. Baran Ç, Durdu S, Dalva K, Zaim Ç, Dogan A, Ocakoglu G, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: A randomized, controlled trial. Stem Cell Rev 2012;8:963-71.
23. Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: A novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg 2009;57:91-5.
24. Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw 2008;19:99-103.
25. Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agrò F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006;34:660-7.
26. Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J 2009;73:2244-9.
27. Kourliouros A, Valencia O, Hosseini MT, Mayr M, Sarsam M, Camm J, et al. Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: A randomized controlled trial. J Thorac Cardiovasc Surg 2011;141:244-8.
28. Mannacio VA, Iorio D, DeAmicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: A randomized trial. J Thorac Cardiovasc Surg 2008;136:1541-8.
29. Spadaccio C, Pollari F, Casacalenda A, Alfano G, Genovese J, Covino E, et al. Atorvastatin increases thenumber of endothelial progenitor cells after cardiac surgery: A randomized control study. J Cardiovasc Pharmacol 2010;55:30-8.
30. Song YB, On YK, Kim JH, Shin DH, Kim JS, Sung J. et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J 2008;156:373.e9-e16.
31. Sun Y, Ji Q, Mei Y, Wang X, Feng J, Cai J, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J 2011;52:7-11.
32. Brown WV, Bays HE, Hassman DR, McKenney J, Chitra R, Hutchinson H, et al. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial. Am Heart J 2002; 144:1036-43.
33. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999;15:394-9.
34. Sun YF, Mei YQ, Ji Q, Wang XS, Feng J, Cai JZ, et al. Effect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Zhonghua Yi Xue Za Zhi 2009;89:2988-91.
35. Tamayo E, Alonso O, Alvarez FJ, Castrodeza J, Flórez S, di Stefano S. Effects of simvastatin on acute-phase protein levels after cardiac surgery. Med Clin (Barc) 2008;130:773-5.
36. Altman DG, Schulz KF. Statistics notes: concealing treatment allocation in randomized trials. BMJ 2001;323:446-7.
37. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
38. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 2001;104:2689-93.
39. Nesher N, Alghamdi AA, Singh SK, Sever JY, Christakis GT, Goldman BS et al. Troponin after cardiac surgery: A predictor or a phenomenon? Ann Thorac Surg 2008;85:1348-54.
40. Asher CR, Miller DP, Grimm RA, Cosgrove DM III, Chung MK. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol 1998;82:892-5.
41. Hravnak M, Hoffman LA, Saul MI, Zullo TG, Whitman GR. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. Am J Crit Care 2002;11:228-38.
42. Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW et al. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ 2011;342:d1250.
43. Yin L, Wang Z, Wang Y, Ji G, Xu Z. Effect of statins in preventing postoperative atrial fibrillation following cardiac surgery. Heart Lung Circ 2010;19:579-83.
44. Dong L, Zhang F, Shu X. Usefulness of statins pretreatment for the prevention of postoperative atrial fibrillation in patients undergoing cardiac surgery. Ann Med 2011;43:69-74.
45. Winchester DE, Wen X, Xie L, Bavry AA. Evidence of pre-procedural statin therapy: A meta-analysis of randomized trials. J Am Coll Cardiol 2010;56:1099-109.
46. Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapyand atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008;51:828-35.
47. Chen WT, Krishnan GM, Sood N, Kluger J, Coleman CI. Effect of statins on atrial fibrillation after cardiac surgery: A duration- And dose-response meta-analysis. J Thorac Cardiovasc Surg 2010;140:364-72.
48. Nordmann AJ, Briel M. Statins: pleiotropic, but less than previously thought. Eur Heart J. 2012;33:1551-2.
49. Chello M, Mastroroberto P, Patti G, D'Ambrosio A, Morichetti MC, Di Sciascio G, et al. Simvastatin attenuates leukocyte-endothelial interactions after coronary revascularization with cardiopulmonary bypass. Heart 2003;89:538.
50. Chello M, Carassiti M, Agrò F, Mastroroberto P, Pugliese G, Colonna D, et al. Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2004;18: 605-9.
51. Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering. Are they clinically relevant? Eur Heart J 2003;24:225-48.
52. Pound EM, Kang JX, Leaf A. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res 2001;42:346-51.
53. Swaanenburg JC, Loef BG, Volmer M, Boonstra PW, Grandjean JG, Mariani MA, et al. Creatine kinase MB, troponin I, and troponinTrelease patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. Clin Chem 2001;47:584-7.
54. Pichon H, Chocron S, Alwan K, Toubin G, Kaili D, Falcoz P et al. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation 1997;96:316-20.
55. Clark LL, Ikonomidis JS, Crawford FA Jr, Crumbley A III, Kratz JM, Stroud MR, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: An 8-year retrospective cohort study. J Thorac Cardiovasc Surg 2006;131:679-85.
56. Pascual DA, Arribas JM, Tornel PL, Marín F, Oliver C, Ahumada M, et al. Preoperative statin therapy and troponinTpredict early complications of coronary artery surgery. Ann Thorac Surg 2006;81:78-83.
57. Ege E, Dereli Y, Kurban S, Sarigül A. Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early afterCABGoperation: An observational study. J Cardiothorac Surg 2010;5:60.
58. Wright DG, Lefer DJ. Statin mediated protection of the ischemic myocardium. Vasc Pharmacol 2005;42:265-70.
59. Atar S, Ye Y, Lin Y, Freeberg SY, Nishi SP, Rosanio S et al. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosyation of cycloxygenase-2. Am J Physiol Heart Circ Physiol 2006;290: H1960-8.
60. Mensah K, Mocanu MM, Yellon DM. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: A potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 2005;45:1287-91.